Wipfli Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

Wipfli Financial Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2K	Buy	+113	New	+$3.15K	﹤0.01%	2277

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wipfli Financial Advisors's EBS Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Emergent Biosolutions (EBS) in Q3 2022: 113 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #2277 among its holdings.

211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

Wipfli Financial Advisors held 113 shares of Emergent Biosolutions worth $2K as of Q3 2022.
Emergent Biosolutions was a new Wipfli Financial Advisors position in Q3 2022.
Emergent Biosolutions made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2277 holding.
211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.